Screener
Tarsus Pharmaceuticals, Inc. TARS Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Tarsus Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s asset turnover?
- Tarsus Pharmaceuticals, Inc. (TARS) reported asset turnover of 1.1× in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s asset turnover changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s asset turnover increased by 61.7% year-over-year, from 0.7× to 1.1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude